I agree that this site is using cookies. You can find further informations here.
X
Miskin, Hari
27  results:
Search for persons X
?
1

Ublituximab, a Novel, Glycoengineered Anti-CD20 Monoclonal ..:

Huang, Deren ; Alvarez, Enrique ; Miskin, Hari..
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
2

Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is As..:

Ribeiro, Marcelo Lima ; Reyes-Garau, Diana ; Vinyoles, Meritxell...
Clinical Cancer Research.  27 (2021)  23 - p. 6591-6601 , 2021
Link: https://doi.org/10.1158/..
 
?
3

Targeting Casein Kinase 1 (CK1) in Hematological Cancers:

Janovská, Pavlína ; Normant, Emmanuel ; Miskin, Hari.
International Journal of Molecular Sciences.  21 (2020)  23 - p. 9026 , 2020
Link: https://doi.org/10.3390/..
 
?
4

Response-adapted, time-limited venetoclax, umbralisib, and ..:

Hill, Brian T. ; Ma, Shuo ; Zent, Clive S....
Blood Advances.  8 (2024)  2 - p. 378-387 , 2024
Link: https://doi.org/10.1182/..
 
?
5

G protein-coupled receptor 183 mediates the sensitization o..:

Ribeiro, Marcelo Lima ; Profitós-Pelejà, Núria ; Santos, Juliana Carvalho...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
6

Poster: IBCL-203: Umbralisib, a PI3Kδ/CK1ε Dual Inhibitor D..:

Ghosh, Nilanjan ; Zinzani, Pier Luigi ; Samaniego, Felipe...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S244 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε..:

Davids, Matthew S. ; O'Connor, Owen A. ; Jurczak, Wojciech...
Blood Advances.  5 (2021)  23 - p. 5332-5343 , 2021
Link: https://doi.org/10.1182/..
 
?
8

IBCL-203: Umbralisib, a PI3Kδ/CK1ε Dual Inhibitor Demonstra..:

Ghosh, Nilanjan ; Zinzani, Pier Luigi ; Samaniego, Felipe...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S404 , 2021
Link: https://doi.org/10.1016/..
 
?
9

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique im..:

Pinilla-Ibarz, Javier ; Sahakian, Eva ; Cleveland, John L....
Blood Advances.  4 (2020)  13 - p. 3072-3084 , 2020
Link: https://doi.org/10.1182/..
 
?
10

A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclo..:

Sawas, Ahmed ; Farber, Charles M. ; Schreeder, Marshall T....
British Journal of Haematology.  177 (2017)  2 - p. 243-253 , 2017
Link: https://doi.org/10.1111/..
 
?
11

Ublituximab (TG‐1101), a novel glycoengineered anti‐CD20 an..:

Sharman, Jeff P. ; Farber, Charles M. ; Mahadevan, Daruka...
British Journal of Haematology.  176 (2016)  3 - p. 412-420 , 2016
Link: https://doi.org/10.1111/..
 
?
12

Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is As..:

Ribeiro, Marcelo Lima ; Reyes, Diana ; Vinyoles, Meritxell...
Instituto de Salud Carlos III PI18/01383.  , 2021
Link: https://ddd.uab.cat/reco..
 
?
13

Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is As..:

Ribeiro, Marcelo Lima ; Reyes-Garau, Diana ; Vinyoles, Meritxell...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401565/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

G protein-coupled receptor 183 mediates the sensitization o..:

Ribeiro, Marcelo Lima ; Profitós-Pelejà, Núria ; Santos, Juliana...
Instituto de Salud Carlos III PI18/01383.  , 2023
Link: https://ddd.uab.cat/reco..
 
?
15

Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Pati..:

Roeker, Lindsey E ; Feldman, Tatyana A ; Soumerai, Jacob D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481719/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15